companydata.dkBILLEV PHARMA ApS: Financial statements 2014
CVR: 81814813
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 9,724,193 and a net result of DKK 516,674 compared with DKK 727,552 the year before. That is an increase of 3.3% compared with the year before. Equity amounted to DKK 1,457,903. The solvency ratio was 27.8%.
- Gross Profit
- 9,724,193 kr.
- Profit/Loss
- 516,674 kr.
- Equity
- 1,457,903 kr.
- Total Assets
- 5,251,626 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 9.7 mio. | 517 t. | 1.5 mio. | - |
| 2013 | - | 9.4 mio. | 728 t. | 2.4 mio. | - |
Keep an eye on BILLEV PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of BILLEV PHARMA ApS.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of BILLEV PHARMA ApS.
About BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees. In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity amounted to DKK 10,525,639.